Search Results

There are 12936 results for: content related to: A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

  1. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients

    Clinical & Experimental Allergy

    Volume 32, Issue 8, August 2002, Pages: 1180–1186, Y. Tohda, M. Fujimura, H. Taniguchi, K. Takagi, T. Igarashi, H. Yasuhara, K. Takahashi and S. Nakajima

    Article first published online : 19 AUG 2002, DOI: 10.1046/j.1365-2745.2002.01440.x

  2. Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in an experimental model of chronic airway inflammation in guinea-pigs

    Clinical & Experimental Allergy

    Volume 34, Issue 1, January 2004, Pages: 145–152, E. A. Leick-maldonado, F. U. Kay, M. C. Leonhardt, D. I. Kasahara, C. M. Prado, F. T. Fernandes, M. A. Martins and I. F. L. C. Tibério

    Article first published online : 14 JAN 2004, DOI: 10.1111/j.1365-2222.2004.01854.x

  3. Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3

    Clinical & Experimental Allergy

    Volume 41, Issue 1, January 2011, Pages: 116–128, T. Kiwamoto, Y. Ishii, Y. Morishima, K. Yoh, N. Kikuchi, N. Haraguchi, H. Masuko, M. Kawaguchi, A. Nomura, T. Sakamoto, S. Takahashi and N. Hizawa

    Article first published online : 16 JUL 2010, DOI: 10.1111/j.1365-2222.2010.03571.x

  4. Adenosine monophosphate bronchial provocation and the actions of asthma therapy

    Clinical & Experimental Allergy

    Volume 33, Issue 3, March 2003, Pages: 287–294, D. K. C. Lee, R. D. Gray and B. J. Lipworth

    Article first published online : 5 MAR 2003, DOI: 10.1046/j.1365-2745.2003.01620.x

  5. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children

    Clinical & Experimental Allergy

    Volume 34, Issue 6, June 2004, Pages: 939–944, A. Gagro, N. Aberle, S. Rabatić, J. Ajduk, J. Jelačić and D. Dekaris

    Article first published online : 14 JUN 2004, DOI: 10.1111/j.1365-2222.2004.01978.x

  6. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

    Clinical & Experimental Allergy

    Volume 32, Issue 7, July 2002, Pages: 1020–1028, G. Philip, K. Malmstrom, F. C. Hampel Jr, S. F. Weinstein, C. F. LaForce, P. H. Ratner, M.-P. Malice, T. F. Reiss and for the Montelukast Spring Rhinitis Study Group

    Article first published online : 5 JUL 2002, DOI: 10.1046/j.1365-2222.2002.01422.x

  7. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma

    Clinical & Experimental Allergy

    Volume 32, Issue 9, September 2002, Pages: 1360–1365, L. Mastalerz, A. Gawlewicz-Mroczka, E. Nizankowska, A. Cmiel and A. Szczeklik

    Article first published online : 6 SEP 2002, DOI: 10.1046/j.1365-2745.2002.01484.x

  8. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges

    Clinical & Experimental Allergy

    Volume 33, Issue 6, June 2003, Pages: 783–788, G. P. Currie, K. Haggart, D. K. C. Lee, S. J. Fowler, A. M. Wilson, J. D. Brannan, S. D. Anderson and B. J. Lipworth

    Article first published online : 10 JUN 2003, DOI: 10.1046/j.1365-2222.2003.01688.x

  9. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells

    Clinical & Experimental Allergy

    Volume 31, Issue 6, June 2001, Pages: 836–844, J. C. Virchow Jr, S. Faehndrich, C. Nassenstein, S. Bock, H. Matthys and W. Luttmann

    Article first published online : 12 JAN 2002, DOI: 10.1046/j.1365-2222.2001.01051.x

  10. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma

    Clinical & Experimental Allergy

    Volume 33, Issue 3, March 2003, Pages: 359–366, A. Y. Wu, S. C. Chik, A. W. Chan, Z. Li, K. W. Tsang and W. Li

    Article first published online : 5 MAR 2003, DOI: 10.1046/j.1365-2222.2003.01615.x

  11. Emerging role of antileukotriene therapy in allergic rhinitis

    Clinical & Experimental Allergy

    Volume 31, Issue 12, December 2001, Pages: 1813–1821, B. J. Lipworth

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1365-2222.2001.01202.x

  12. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma

    Clinical & Experimental Allergy

    Volume 35, Issue 2, February 2005, Pages: 213–220, I. Stelmach, P. Majak, J. Jerzynska and P. Kuna

    Article first published online : 21 FEB 2005, DOI: 10.1111/j.1365-2222.2005.02154.x

  13. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study

    Clinical & Experimental Allergy

    Volume 34, Issue 9, September 2004, Pages: 1401–1407, E. Nettis, M. C. Colanardi, M. T. Paradiso and A. Ferrannini

    Article first published online : 19 JUL 2004, DOI: 10.1111/j.1365-2222.2004.02019.x

  14. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

    Clinical & Experimental Allergy

    Volume 32, Issue 1, January 2002, Pages: 126–132, A. M. Wilson, L. C. Orr, W. J. R. Coutie, E. J. Sims and B. J. Lipworth

    Article first published online : 28 FEB 2002, DOI: 10.1046/j.0022-0477.2001.01252.x

  15. Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity

    Clinical & Experimental Allergy

    Volume 38, Issue 5, May 2008, Pages: 805–811, F. Tahan, E. Jazrawi, T. Moodley, G. E. Rovati and I. M. Adcock

    Article first published online : 5 MAR 2008, DOI: 10.1111/j.1365-2222.2008.02963.x

  16. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and bβ-agonist treatment on IL-10 serum levels in children with asthma

    Clinical & Experimental Allergy

    Volume 32, Issue 2, February 2002, Pages: 264–269, I. Stelmach, J. Jerzynska and P. Kuna

    Article first published online : 8 APR 2002, DOI: 10.1046/j.1365-2222.2002.01286.x

  17. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism

    Clinical & Experimental Allergy

    Volume 32, Issue 5, May 2002, Pages: 745–750, L. Fregonese, M. Silvestri, F. Sabatini and G. A. Rossi

    Article first published online : 2 MAY 2002, DOI: 10.1046/j.1365-2222.2002.01384.x

  18. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older

    Clinical & Experimental Allergy

    Volume 31, Issue 6, June 2001, Pages: 845–854, B. Williams, G. Noonan, T. F. Reiss, B. Knorr, J. Guerra, R. White and J. Matz

    Article first published online : 12 JAN 2002, DOI: 10.1046/j.1365-2222.2001.01085.x

  19. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep

    Clinical & Experimental Allergy

    Volume 39, Issue 9, September 2009, Pages: 1404–1414, M. Shichijo, A. Arimura, Y. Hirano, K. Yasui, N. Suzuki, M. Deguchi and W. M. Abraham

    Article first published online : 26 MAY 2009, DOI: 10.1111/j.1365-2222.2009.03275.x

  20. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma

    Clinical & Experimental Allergy

    Volume 29, Issue 1, January 1999, Pages: 42–51, DIAMANT, GROOTENDORST, VESELIC-CHARVAT, TIMMERS, DE SMET, LEFF, SEIDENBERG, ZWINDERMAN, PESZEK and STERK

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2222.1999.00447.x